Precision Biosciences DTIL
NASDAQ DTIL
$6.31 -0.02 (-0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Precision Biosciences' Return on Capital Employed [ROCE] was -28.49% in fiscal Q2 2026 (quarter ended Jun 30, 2026), up 58.91 percentage points from -87.40% a year earlier but down 0.83 percentage points from the prior quarter.

Analysis

Precision Biosciences (DTIL) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025 (ended Dec 31, 2025), Return on Capital Employed [ROCE] at Precision Biosciences came in at -38.21%, down 18.55 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +35.08 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Capital Employed [ROCE] was -19.66% in FY2024 (+9.70 pp), -29.36% in FY2023 (+8.37 pp), -37.72% in FY2022 (-10.54 pp) and -27.18% in FY2021 (+46.10 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -103.80% (fiscal Q3 2025) and -5.13% (fiscal Q2 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of -12.85 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q4 2021 (a gain of 72.72 percentage points); the worst was fiscal Q3 2025 (a drop of 92.82 percentage points).
  • Per Business Quant data, DTIL's Return on Capital Employed [ROCE] in the three fiscal quarters before Q2 2026 was -27.66% (Q1 2026), -45.33% (Q4 2025) and -103.80% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Precision Biosciences 166.80 Mn -182.39 Mn - -28.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.49%
Mar 31, 2026 -27.66%
Dec 31, 2025 -45.33%
Sep 30, 2025 -103.80%
Jun 30, 2025 -87.40%
Mar 31, 2025 -37.36%
Dec 31, 2024 -20.15%
Sep 30, 2024 -10.98%
Jun 30, 2024 -5.13%
Mar 31, 2024 -24.88%
Dec 31, 2023 -39.02%
Sep 30, 2023 -33.46%
Jun 30, 2023 -31.65%
Mar 31, 2023 -39.94%
Dec 31, 2022 -42.85%
Sep 30, 2022 -45.81%
Jun 30, 2022 -53.50%
Mar 31, 2022 -28.67%
Dec 31, 2021 -21.47%
Sep 30, 2021 -16.72%
API Access

Precision Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DTIL&period=max&api_key=YOUR_API_KEY